JCJuan José Cortez-Escalante

Juan José Cortez-Escalante

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Juan José Cortez-Escalante has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Avaliação do sistema de vigilância entomológica da doença de Chagas com participação comunitária em Mambaí e Buritinópolis, Estado de Goiás

    by Antonio Carlos Silveira, Dilermando Fazito de Rezende, Ana Maria Nogales, Juan José Cortez-Escalante, Cleudson Castro, Vanize Macêdo

    A vigilância entomológica da doença de Chagas em Mambaí e Buritinópolis, no Estado de Goiás, Brasil, tem sido mantida com participação da população, notificando a presença de vetores nas habitações. Passado longo tempo após instituídas as ações de controle e tendo-se já certificado a interrupção da transmissão vetorial, buscou-se avaliar o conhecimento e as práticas da população nessa situação. Os resultados apontam progressivo desinteresse pelo tema doença de Chagas, atribuível à redução da magnitude do problema representado pela enfermidade, a pouca participação das escolas na vigilância, à pequena importância dos vetores secundários e nativos e, em conseqüência, às limitadas intervenções dos serviços de controle em resposta às notificações. Propõe-se, que atividades de busca direta por amostragem sejam periodicamente realizadas e maior envolvimento das instituições de ensino.


  • Open Access

    Tuberculosis incidence and risk factors among patients living with HIV/AIDS in public health service institutions in Brasilia, Federal District

    by Leonor Henriette de Lannoy, Juan José Cortez-Escalante, Maria Do Socorro Nantua Evangelista, Gustavo Adolfo Sierra Romero

    In order to estimate the incidence of and risk factors for developing tuberculosis, the clinical charts of a retrospective cohort of 281 HIV-positive adults, who were notified to the AIDS Program of the Health Department of Brasilia in 1998, were reviewed in 2003. All the patients were treatment-naive regarding antiretroviral therapy at the time of inclusion in the cohort. Twenty-nine patients were identified as having tuberculosis at the start of the study. Thirteen incident tuberculosis cases were identified during the 60 months of follow-up, with an incidence density rate of 1.24/100 person-years. Tuberculosis incidence was highest among patients with baseline CD4+ T-lymphocyte counts < 200 cells/µl who were not using antiretroviral therapy (incidence = 5.47; 95% CI = 2.73 to 10.94). Multivariate analysis showed that baseline CD4+ T-lymphocyte counts < 200 cells/µl (adjusted hazard ratio [AHR] = 5.09; 95% CI = 1.27 to 20.37; p = 0.02) and non-use of antiretroviral therapy (AHR = 12.17; 95% CI = 2.6 to 56.90; p = 0.001) were independently associated with increased risk of tuberculosis.


  • Open Access

    Pulmonary thromboembolism in AIDS patient with chronic venous insufficiency, pulmonary tuberculosis and breast cancer: a case report and pathophysiology review

    by Juan José Cortez-Escalante, Cleudson Castro, Gustavo Adolfo Sierra Romero, Luiza Matos, Muhammad Wasif Saif

    Recent literature reports thrombotic episodes occurring in patients with HIV infection associated with other abnormalities including neoplasms and infections predisposing to a hypercoagulable state. We report a 47-year-old woman who developed pulmonary thromboembolism in association with HIV infection, pulmonary tuberculosis and breast cancer. She was treated with rifampin, isoniazid, pyrazinamide; heparin, phenprocoumon, zidovudine, lamivudine and efavirenz. Acid fast bacilli were visualized in a sputum smear and three months after, Mycobacterium tuberculosis was isolated from lymph node biopsy during a episode of immune reconstitution. The isolated mycobacteria showed sensitivity to all first-line drugs. HIV infection, breast cancer and pulmonary tuberculosis have several mechanisms that induce hypercoagulable state and can lead to thromboembolic complications. Pulmonary thromboembolism in this patient was a diagnostic challenge because of all the other severe diseases that she experienced at the same time.